The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Massachusetts General Hospital
100 participants
Apr 15, 2024
OBSERVATIONAL
Conditions
Summary
Recurrent respiratory papillomatosis (RRP) is an orphan disease that affects approximately 20,000 people in the United States and is caused by infection with human papillomavirus (HPV) types 6 and 11. Since RRP is an orphan disease, it is an understudied disease entity with correspondingly few treatment options. The investigators hypothesize that by understanding the biology of RRP and the failed host immune responses against HPV, novel and rational therapies can be developed. This study will examine the genetic and immunologic alterations found in these rare tumors and distant metastatic involved sites (such as the lung) in patients diagnosed with RRP.
Eligibility
Inclusion Criteria2
- History of HPV-associated Recurrent Respiratory Papillomatosis
- Has pulmonary lesions
Exclusion Criteria1
- None
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06412172